Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US.

Both race/ethnicity and treatment timing significantly affected survival time, and this association remained after adjustment for known prognostic factors. Additional research is necessary to disentangle the specific causal factors, and the mechanism with which they affect survival.